This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_ASTROCYTOMA_EXALLC for full statistics.
Brain astrocytoma
C3_ASTROCYTOMA
astrocytoma: A glial tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, and glioblastoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
143 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
143 |
4. Check minimum number of eventsNone |
143 |
5. Include endpoints |
143 |
6. Filter based on genotype QC (FinnGen only) |
143 |
Control definitions (FinnGen only)
- Control conditions
- not HLP_C3_ASTROCYTOMA
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Brain astrocytoma
based on the number of shared cases.
Similar with more cases:
- Brain astrocytoma, excluding all cancers (controls excluding all cancers)
- Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)
- Brain glioblastoma and astrocytoma
- Malignant neoplasm of brain
- Malignant neoplasm of eye, brain and central nervous system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 143 | 71 | 72 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 40.83 | 38.49 | 43.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 135
- Matched controls
- 1349
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3628.2
123.3
100
*
L01AX03
ATC
temozolomide; systemic
+∞
112.9
92
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
199.2
109.3
106
24
130
Kela drug reimbursment
Malignant tumour
114.6
96.1
102
35
N03AX14
ATC
levetiracetam; systemic
226.5
82.1
78
8
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
77.8
67
*
H02AB02
ATC
dexamethasone; systemic
60.3
77.8
94
49
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
252.6
76.2
72
6
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
51.6
74.4
94
57
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
824.3
57.0
52
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
215.2
54.4
53
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
53.8
48
*
A04AA02
ATC
granisetron; systemic, transdermal
42.0
51.7
65
29
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
51.4
46
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
49.0
44
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
177.9
47.3
47
*
N03AF02
ATC
oxcarbazepine; oral
97.9
47.2
50
8
ZXC95
NOMESCO Finland
Use of surgical navigator
172.2
46.1
46
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
322.6
46.0
44
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
71.0
44.9
50
11
WF002
NOMESCO Finland
Radical radiotherapy
36.4
37.4
48
20
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
49.3
37.0
44
13
AA1AD
NOMESCO Finland
CT of head and brain
12.8
36.0
76
123
A03FA01
ATC
metoclopramide; systemic, rectal
12.0
34.9
77
134
XA800
NOMESCO Finland
Neuropsychological investigation
33.7
33.7
44
19
R56.8
ICD-10 Finland
Other and unspecified convulsions
21.4
33.5
51
37
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
32.6
30
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
72.0
29.7
33
6
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
29.2
27
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
15.9
28.1
48
45
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
116.8
26.8
28
*
N03AX18
ATC
lacosamide; systemic
+∞
24.7
23
*
XX3DW
NOMESCO Finland
Time consuming IT work
12.6
24.2
46
53
ZXC40
NOMESCO Finland
Use of ultrasound
79.7
23.8
26
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
27.5
23.5
32
15
N03AB02
ATC
phenytoin; systemic
274.7
23.4
23
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
22.5
21
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
8.6
22.4
55
100
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
21.4
20
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
130.3
21.3
22
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
20.3
19
*
A04AA01
ATC
ondansetron; systemic, rectal
13.1
19.4
35
35
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
52.1
18.9
22
5
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
77.5
18.3
20
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
109.7
18.1
19
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.2
17.8
75
260
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
58.2
17.5
20
*
WX882
NOMESCO Finland
High dependency care
32.4
17.1
22
8
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
15.9
15
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
180.0
15.8
16
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
90.2
14.9
16
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
14.9
14
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
167.4
14.8
15
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
167.4
14.8
15
*
N05BA09
ATC
clobazam; oral
83.5
13.9
15
*
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
13.8
13
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
13.8
13
*
N03AG01
ATC
valproic acid; systemic, rectal
8.2
13.5
31
47
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
14.3
13.2
22
18
Z51.5
ICD-10 Finland
Palliative care
14.3
13.2
22
18
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
12.7
12
*
A02BC02
ATC
pantoprazole; systemic
4.0
12.5
100
559
H53.4
ICD-10 Finland
Visual field defects
41.8
12.5
15
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
51.6
12.1
14
*
N03AF01
ATC
carbamazepine; oral, rectal
11.2
11.8
22
23
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
11.6
11
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
11.6
11
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
11.6
11
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
65.3
10.8
12
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
10.5
10
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
10.5
10
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
10.5
10
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
25.8
10.5
14
6
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
43.6
10.1
12
*
183
Kela drug reimbursment
Lamotrigin and topiramate
22.1
10.0
14
7
AA1BD
NOMESCO Finland
Extensive CT of head and brain
19.3
9.6
14
8
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
32.6
9.6
12
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
107.2
9.5
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.1
9.5
41
130
G40
ICD-10 Finland
Epilepsy
+∞
9.5
9
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
9.5
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
9.3
8.9
18
22
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
53.5
8.8
10
*
G40.10
ICD-10 Finland
Simple partial seizures
29.7
8.6
11
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
+∞
8.4
8
*
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
8.4
8
*
WX872
NOMESCO Finland
Intensive care
7.8
8.1
18
26
WZC30
NOMESCO Finland
Teaching
4.5
7.9
29
78
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
47.8
7.8
9
*
ZXM40
NOMESCO Finland
Use of fluorescent substance
+∞
7.4
7
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.4
7
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
7.4
7
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
7.4
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
7.2
48
207
R47.0
ICD-10 Finland
Dysphasia and aphasia
42.2
6.8
8
*
N05CD08
ATC
midazolam; nasal, systemic
23.9
6.8
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
15.3
6.5
10
7
ZX070
NOMESCO Finland
Intensity modified radiotherapy
15.3
6.5
10
7
N03AX23
ATC
brivaracetam; systemic
73.2
6.5
7
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
73.2
6.5
7
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
73.2
6.5
7
*
WX402
NOMESCO Finland
General anaesthesia
3.4
6.4
34
123
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
+∞
6.3
6
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
6.3
6
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
6.1
27
86
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
44
10
63.11
76.41
2.0
1.9
—
—
—
0
0
(4035726)
82
91
19.78
75.19
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
70
101
12.62
51.47
5.5
13.6
mmol/l
0.8
1.9
1.95
51
77
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
50
52
14.25
45.83
4.0
4.1
mmol/l
23.8
25.1
1.50
50
52
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
16
16.07
24.19
2.0
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
107
470
6.07
22.10
6.7
7.9
mmol/l
1.2
1.2
1.21
95
400
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
257
4.89
20.02
1.9
2.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
15
13.58
18.15
1.8
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
84
351
4.38
17.17
2.2
2.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
29
53
6.61
16.00
5.9
11.1
%
96.4
94.8
1.88
29
53
(40768804) Tissue Pathology biopsy report
91
422
4.18
15.64
3.3
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
33
7.70
14.48
1.9
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
100
528
3.97
13.51
3.3
4.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
78
357
3.61
13.00
4.0
7.2
inr
1.0
1.2
1.72
20
106
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
9
21.20
11.91
1.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
47
5.64
11.17
7.7
20.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
20
38
5.96
10.45
1.7
1.3
e6/l
34.3
2.1
1.24
14
28
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
20
38
5.96
10.45
1.8
1.4
e6/l
1025.9
31.1
0.48
15
30
(3013650) Neutrophils [#/volume] in Blood by Automated count
111
692
3.70
10.33
16.6
9.7
e9/l
3.4
4.0
3.14
100
611
(42870588) Differential panel, method unspecified - Blood
76
381
3.12
10.27
8.6
6.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
66
330
2.86
8.60
7.5
3.8
mmol/l
2.4
2.4
0.81
59
290
(3019060) Gas panel - Arterial blood
22
56
4.46
8.23
5.4
14.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
96
604
2.79
7.73
9.1
6.9
e9/l
0.1
0.2
9.54
85
548
(3006315) Basophils [#/volume] in Blood
94
587
2.75
7.65
9.2
6.3
e9/l
0.0
0.0
4.12
82
528
(3001604) Monocytes [#/volume] in Blood
94
587
2.75
7.65
9.1
6.3
e9/l
0.5
0.6
0.71
83
525
(3019069) Monocytes/100 leukocytes in Blood
90
559
2.65
7.26
9.4
6.7
%
9.3
8.5
1.64
90
540
(3022096) Basophils/100 leukocytes in Blood
88
543
2.61
7.16
9.3
6.6
%
0.5
0.7
3.85
88
518
(3006504) Eosinophils/100 leukocytes in Blood
89
554
2.61
7.08
9.2
6.4
%
2.1
2.8
3.47
89
533
(3018010) Neutrophils/100 leukocytes in Blood
90
569
2.57
6.84
9.3
6.3
%
60.0
57.2
1.18
90
549
(3019198) Lymphocytes [#/volume] in Blood
93
608
2.51
6.42
9.3
6.4
e9/l
1.4
1.8
7.98
83
551
(3002030) Lymphocytes/100 leukocytes in Blood
90
580
2.49
6.40
9.5
6.4
%
26.3
28.6
1.00
90
558
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
8
13.31
6.18
1.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
64
365
2.36
5.85
1.3
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
78
3.32
5.72
8.0
7.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
17
6.25
5.71
1.9
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
47
250
2.31
4.91
3.4
4.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
91
1139
0.45
4.80
2.8
3.8
mmol/l
4.8
4.7
0.48
81
1077
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
93
1151
0.45
4.62
2.9
4.0
mmol/l
3.0
2.9
0.74
81
1078
(40758558) Short blood count panel - Blood
50
281
2.20
4.53
10.0
7.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
91
1133
0.46
4.52
2.8
3.7
mmol/l
1.4
1.4
0.45
81
1067
(3021589) Normoblasts [#/volume] in Blood
74
489
2.06
4.35
12.8
9.2
e9/l
0.0
0.0
0.39
62
403
(3013512) EKG study
44
244
2.16
4.07
3.2
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
58
363
2.01
3.86
2.7
3.1
ng/l
13.8
32.9
1.40
38
202
(3018418) pH of Serum or Plasma
49
293
2.02
3.67
2.6
3.8
ph
7.4
7.4
—
9
51
(3019225) pH of Specimen
20
81
2.71
3.65
3.4
4.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
72
944
0.52
3.57
3.3
3.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
89
1092
0.51
3.53
2.8
3.4
mmol/l
1.3
1.3
0.14
80
1018
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
8
7.76
3.08
3.0
3.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
8
7.76
3.08
1.5
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
17
4.92
2.96
1.1
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
18
4.64
2.84
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
106
2.27
2.81
7.6
8.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
99
1152
0.54
2.70
27.0
12.7
%
38.7
41.2
1.54
76
955
(3005322) IgE [Units/volume] in Serum or Plasma
0
71
0.00
2.66
0.0
1.2
—
504.7
—
0
63
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
7
7.35
2.57
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
16
4.54
2.50
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
11
253
0.39
2.47
2.5
4.2
mg/mmol
1.9
10.8
—
5
166
(3020891) Body temperature
10
34
3.09
2.46
3.0
6.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.71
2.23
1.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
55
0.00
2.12
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
55
0.00
2.12
0.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
85
1003
0.62
1.96
3.2
4.6
mmol/mol
35.9
38.6
4.17
74
960
(3022806) Fractional oxyhemoglobin in Capillary blood
5
11
4.67
1.95
1.4
1.1
%
93.0
91.9
—
5
11
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
93
1074
0.62
1.93
3.6
3.7
mmol/l
5.5
5.8
2.55
84
1000
(3027315) Oxygen [Partial pressure] in Blood
7
22
3.29
1.90
3.1
2.4
kpa
8.8
9.1
—
7
22
(3013290) Carbon dioxide [Partial pressure] in Blood
7
22
3.29
1.90
3.1
2.4
kpa
5.2
5.0
—
7
22
(3012501) Base excess in Blood by calculation
7
22
3.29
1.90
3.1
2.4
mmol/l
2.3
2.5
—
7
15
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
54
0.00
1.90
0.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
17
87
2.08
1.89
3.8
3.4
%
1.8
1.0
—
9
24
(1616796) Gas panel - Central venous blood
6
19
3.25
1.68
2.8
2.6
—
—
—
0
0
(3015736) pH of Urine
30
437
0.60
1.66
3.2
2.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
127
1154
1.90
1.63
22.6
12.5
mmol/l
139.1
139.7
1.16
127
1126
(3023103) Potassium [Moles/volume] in Serum or Plasma
127
1157
1.87
1.57
21.8
12.6
mmol/l
3.9
3.9
1.47
127
1126
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
37
2.53
1.51
1.2
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
45
2.31
1.50
1.5
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
195
0.48
1.47
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
120
0.40
1.45
1.2
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
7
146
0.45
1.42
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
192
0.48
1.41
1.8
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
287
0.57
1.39
1.7
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
34
464
0.65
1.37
1.9
2.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
54
2.12
1.37
1.0
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
38
0.00
1.36
0.0
1.3
—
15.5
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
41
0.00
1.33
0.0
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
98
1091
0.68
1.30
30.8
14.9
g/l
336.4
334.2
1.28
98
1086
(3010813) Leukocytes [#/volume] in Blood
128
1345
0.54
1.29
34.3
17.4
e9/l
6.5
6.6
0.07
128
1310
(3024731) MCV [Entitic volume]
128
1344
0.55
1.24
34.3
17.4
fl
90.7
90.2
0.61
128
1328
(3035941) MCH [Entitic mass]
128
1344
0.55
1.24
34.2
17.3
pg
30.5
30.2
1.43
128
1328
(3000963) Hemoglobin [Mass/volume] in Blood
128
1344
0.55
1.24
35.3
17.5
g/l
135.9
138.9
1.68
128
1328
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
37
2.23
1.23
1.1
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
14
80
1.83
1.18
3.4
3.6
%
0.1
0.3
—
7
19
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
34
0.00
1.17
0.0
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
128
1342
0.56
1.16
34.3
17.4
e9/l
246.4
251.7
0.24
128
1310
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
162
1.58
1.13
1.8
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
122
0.47
1.11
1.2
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
21
2.43
1.10
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
28
381
0.67
1.08
1.9
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
211
0.58
1.07
1.3
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
36
272
1.43
1.01
2.2
2.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
11
183
0.57
0.99
2.3
2.7
ug/l
0.8
0.8
—
5
111
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
29
0.00
0.99
0.0
2.0
—
0.0
—
0
29
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.99
0.0
2.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
30
0.00
0.98
0.0
1.2
—
4.3
—
0
16
(4094501)
0
30
0.00
0.98
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
32
0.00
0.96
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
155
0.55
0.95
1.3
2.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
81
706
1.34
0.93
3.2
4.0
—
76.2
—
0
9
(3000492) Spirometry study
7
127
0.53
0.93
1.1
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
137
0.56
0.89
2.4
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
86
760
1.33
0.88
3.1
4.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
26
190
1.45
0.87
2.0
2.8
ng/l
1867.0
722.6
—
10
119
(3035350) Ketones [Presence] in Urine by Test strip
45
545
0.75
0.85
2.8
3.1
estimate
0.0
0.0
—
8
105
(3022145) Colonoscopy Study observation
7
124
0.54
0.82
1.1
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
117
1090
1.40
0.80
19.2
10.4
ml/min/173m2
98.9
91.6
4.15
106
858
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
25
0.00
0.80
0.0
1.2
—
—
—
0
0
(4306422)
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
27
0.00
0.78
0.0
2.0
—
0.0
—
0
27
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
27
0.00
0.78
0.0
2.0
—
0.0
—
0
27
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
201
0.66
0.70
1.4
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
23
300
0.72
0.69
1.4
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
46
542
0.78
0.68
4.3
4.5
estimate
0.0
0.0
—
8
103
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
125
1187
1.42
0.66
20.1
11.8
mg/l
19.6
21.0
0.28
116
918
(3009261) Glucose [Presence] in Urine by Test strip
47
550
0.78
0.66
2.9
3.2
estimate
0.0
0.0
—
8
97
(3044889) 12 lead EKG panel
79
708
1.26
0.65
2.9
3.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
29
1.75
0.64
1.0
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
8
50
1.63
0.62
1.4
3.5
—
7.4
—
0
7
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
16
114
1.45
0.62
1.7
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
30
1.69
0.62
1.2
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
30
1.69
0.62
1.2
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
14
97
1.49
0.61
2.3
2.3
—
18.0
—
0
7
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
167
1.38
0.61
2.9
2.4
e6/l
4.8
2.9
0.24
14
80
(3024928) Oxygen saturation in Venous blood
0
20
0.00
0.61
0.0
3.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
(4268621)
0
22
0.00
0.60
0.0
2.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
23
0.00
0.59
0.0
2.2
—
2.7
—
0
18
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
6
38
1.60
0.55
2.7
2.2
g/l
3.3
3.6
—
6
38
(3002256) Pathology report gross observation
9
134
0.65
0.55
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
22
278
0.75
0.54
1.0
1.4
g/l
1.7
2.4
—
10
175
(3022621) pH of Urine by Test strip
10
66
1.55
0.54
2.0
2.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
144
1.37
0.54
1.2
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
172
1.33
0.52
2.8
2.3
e6/l
0.8
0.6
0.24
14
85
(40760892) CBC W Ordered Manual Differential panel - Blood
34
283
1.26
0.51
7.4
4.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
232
0.74
0.51
2.3
3.9
%
22.5
21.9
—
7
100
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
99
1051
0.81
0.50
3.9
4.4
mu/l
1.7
1.7
0.41
92
982
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
263
0.76
0.49
2.0
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
111
1.39
0.49
2.0
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
68
1.51
0.48
2.0
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
20
251
0.76
0.47
2.6
3.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
81
0.60
0.47
2.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
82
0.60
0.47
2.6
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
82
0.60
0.47
2.4
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
39
450
0.82
0.46
2.2
2.3
nmol/l
77.3
74.1
0.30
34
417
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
37
429
0.81
0.46
3.2
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
238
0.77
0.44
1.9
2.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
32
1.58
0.42
1.4
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
32
1.58
0.42
1.4
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
16
0.00
0.41
0.0
3.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
98
1034
0.83
0.41
28.7
14.3
%
13.4
13.4
0.18
98
1018
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
17
0.00
0.41
0.0
2.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
35
1.44
0.39
1.6
3.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
77
0.64
0.37
1.0
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
80
0.61
0.36
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
24
283
0.82
0.35
2.9
3.3
estimate
0.0
0.0
—
8
103
(3036489) Thrombin time
6
45
1.35
0.34
2.3
1.9
s
20.5
21.4
—
6
39
(3041096) Erythrocytes [Presence] in Urine by Automated
28
322
0.84
0.32
2.8
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
111
1.29
0.31
1.0
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
57
1.24
0.29
1.7
1.5
u/l
10.2
7.0
—
7
47
(3000494) Fungus identified in Specimen by Culture
9
118
0.75
0.28
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
18
214
0.82
0.28
1.4
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
139
0.77
0.28
1.1
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
67
1.21
0.27
1.8
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
72
0.68
0.27
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
72
0.68
0.27
1.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
72
0.68
0.27
1.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
72
0.68
0.27
1.0
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
73
1.25
0.26
1.7
1.4
iu/l
18.6
22.4
—
9
65
(3001122) Ferritin [Mass/volume] in Serum or Plasma
48
520
0.88
0.25
2.0
2.6
ug/l
91.0
90.3
0.01
42
495
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
37
1.36
0.24
2.2
4.4
%
43.7
62.4
—
5
37
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
11
88
1.27
0.23
1.4
2.8
g/l
0.3
0.2
0.81
11
83
(3019309) Folate [Moles/volume] in Red Blood Cells
17
144
1.20
0.23
1.9
1.6
nmol/l
1369.3
1159.2
—
9
112
(3000330) Specific gravity of Urine by Test strip
5
39
1.29
0.23
5.6
3.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
39
1.29
0.23
2.8
2.2
%
185.4
180.3
—
5
39
(40768795) Lymph node Pathology biopsy report
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4198724)
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
11
0.00
0.21
0.0
3.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
8.9
—
0
11
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
4.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
2.4
—
17.4
—
0
10
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
1.4
—
13.2
—
0
10
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
3.2
—
0
12
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
147.6
—
0
13
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
8.9
—
0.6
—
0
14
(3004616) Nuclear Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
4.2
—
3.1
—
0
14
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
154
0.83
0.20
1.5
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
69
0.71
0.17
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
80
0.74
0.16
1.0
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
32
296
1.10
0.14
2.5
2.5
e6/l
0.1
0.2
0.12
24
219
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
40
375
1.09
0.14
2.4
2.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
8
96
0.82
0.14
1.0
1.3
iu/ml
—
150.2
—
0
31
(3018095) Leukocytes [#/volume] in Urine
37
395
0.91
0.14
2.8
3.1
e6/l
49.5
48.1
0.01
27
270
(36304419) Bacteria [Presence] in Urine
32
297
1.10
0.14
2.0
2.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
23
251
0.90
0.13
1.3
1.8
mg/l
0.7
1.1
1.08
13
194
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
54
1.12
0.09
1.2
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3012544) pH of Venous blood
10
88
1.15
0.08
1.7
4.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
72
0.83
0.08
1.8
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
90
0.88
0.07
2.4
3.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
86
876
0.95
0.06
3.6
3.0
u/l
46.7
41.2
0.39
80
849
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
12
109
1.11
0.06
3.9
3.8
%
24.9
32.3
—
7
69
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
83
842
0.97
0.04
3.6
3.9
pmol/l
14.3
14.5
0.31
77
787
(3007853) Bacteria identified in Skin by Aerobe culture
12
128
0.93
0.02
1.2
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
126
1252
1.05
0.02
20.6
10.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
34
333
1.03
0.01
2.5
2.5
e6/l
26.2
246.0
0.59
26
257
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
127
1274
0.97
0.00
18.1
9.3
u/l
28.1
28.4
0.06
127
1250
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
6
0.00
0.00
0.0
1.3
—
229.7
—
0
6
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
98
0.91
0.00
1.6
1.5
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
11.9
—
0
6
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
20.8
—
0
8
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
20.8
—
0
5
(3044941) Cell count panel - Synovial fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
90
1.00
0.00
3.7
3.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
36
360
1.00
0.00
1.7
1.8
pmol/l
99.2
99.8
0.03
19
181
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.3
—
0
6
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
6
68
0.88
0.00
2.0
2.3
ug/l
10.1
6.2
—
6
60
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.8
—
8.9
—
0
6
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ASTROCYTOMA – Brain astrocytoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).